Name | Acazicolcept |
---|
Description | Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities[1]. |
---|---|
Related Catalog | |
In Vivo | Azacicolcept (267-400 μg/mouse; i.p.; twice a week; for 6 weeks) 可减少皮肤和肺纤维化并缓解肺动脉高压[1]。 Animal Model: Six-week-old female BALB/c mice induced by hypochlorous acid (HOCL)[1] Dosage: 267 μg/mouse and 400 μg/mouse Administration: i.p.; twice a week; for 6 weeks Result: Induced a significant decrease in dermal thickness, collagen content, myofibroblast number, and inflammatory infiltrates characterized by B cells, T cells, neutrophils, and macrophages. |
References |
No Any Chemical & Physical Properties |